Loïc Vincent, Ph.D., Chief Scientific Officer at Korro Bio, brings over 20 years of experience in drug discovery & translational research across academia, biotech and the pharmaceutical industry, with deep expertise in oncology and immunology-related disorders. Throughout his career, Dr. Vincent led teams that advanced more than 20 drugs into clinical development based on various therapeutic modalities including small molecules, biologics, viral platforms, and cell therapies.
Prior to joining Korro, Dr. Vincent served as Chief Scientific Officer at Affini-T Therapeutics leading efforts to advance next-generation therapies. Previously, he was Head of the Oncology Drug Discovery Unit and Immunology Unit at Takeda. Before that, Dr. Vincent led Oncology Drug Discovery Pharmacology, Immunotherapy and Oncology External Innovation teams at Sanofi, and earlier in his career, he headed Pharmacology and Oncology programs at Endotis Pharma. Dr. Vincent currently serves on the Scientific Advisory Boards of bit.bio and General Inception, and is a Director on the Board of Alaya.bio. Dr. Vincent obtained his Ph.D. in pharmacology from the University of Rouen, France, and completed his postdoctoral fellowship in oncology at the Weill Medical College of Cornell University, New York.
What is Loïc A. Vincent's net worth?
The estimated net worth of Loïc A. Vincent is at least $210.78 thousand as of June 16th, 2026. Dr. Vincent owns 18,297 shares of Korro Bio stock worth more than $210,781 as of August 5th. This net worth approximation does not reflect any other assets that Dr. Vincent may own. Learn More about Loïc A. Vincent's net worth.
How do I contact Loïc A. Vincent?
Has Loïc A. Vincent been buying or selling shares of Korro Bio?
Loïc A. Vincent has not been actively trading shares of Korro Bio during the last quarter. Most recently, Loic A. Vincent sold 3,418 shares of the business's stock in a transaction on Tuesday, June 16th. The shares were sold at an average price of $10.83, for a transaction totalling $37,016.94. Following the completion of the sale, the insider now directly owns 18,297 shares of the company's stock, valued at $198,156.51. Learn More on Loïc A. Vincent's trading history.
Are insiders buying or selling shares of Korro Bio?
During the last twelve months, Korro Bio insiders bought shares 9 times. They purchased a total of 1,657,320 shares worth more than $18,412,560.00. During the last twelve months, insiders at the sold shares 9 times. They sold a total of 306,026 shares worth more than $4,309,636.75. The most recent insider tranaction occured on July, 6th when Director Jean Francois Formela sold 9,323 shares worth more than $130,149.08. Insiders at Korro Bio own 4.8% of the company.
Learn More about insider trades at Korro Bio. Information on this page was last updated on 7/6/2026.
